Industry News

Jul 18, 2018
By Pharmaceutical Technology Editors
Both parties have agreed to recognize each other’s inspection of manufacturing sites for a broader range of medicines, including sterile products, APIs, biologics, and vaccines.
Jul 16, 2018
By Pharmaceutical Technology Editors
Teva Pharmaceuticals, Major Pharmaceuticals, and Solco Healthcare are voluntarily recalling their products containing valsartan because of the presence of N-nitrosodimethylamine.
Jul 12, 2018
By Pharmaceutical Technology Editors
The agency is releasing six new draft guidances to provide a regulatory framework for handling gene therapies.
Jul 12, 2018
By Pharmaceutical Technology Editors
CPhI Korea to feature zone for finished dosage formulation drug products.
Jul 10, 2018
By Pharmaceutical Technology Editors
Findings from a survey show that some companies have not yet taken the necessary steps to ensure the continuity of medicine supply in the European Union after the United Kingdom’s departure.
Jul 10, 2018
By Pharmaceutical Technology Editors
Progressive Care’s DischargeRX program works with hospitals and patients to help improve patient medication adherence and minimize medication-related hospital readmissions.
Jul 10, 2018
By Pharmaceutical Technology Editors
Annual awards program recognizes innovation in bio/pharmaceutical drug development and manufacturing.
Jul 09, 2018
By Pharmaceutical Technology Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 05, 2018
By Pharmaceutical Technology Editors
The agency is reviewing products containing valsartan supplied by Zhejiang Huahai Pharmaceuticals, a company in Linhai, China.
Jul 03, 2018
By Pharmaceutical Technology Editors
The agency published guidance on how the Generic Drug User Fee Amendments Reauthorization of 2017 applies to amendments to ANDAs and PASs.
native1_300x100
lorem ipsum